Replies to post #4199 on Amarin Corp Plc (AMRN)

[Biobillionair]

Forgot the diabetes link...

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088807/

These APO 3 C results, opens Icosapent Ethyl to be studied in depth in the diabetic, pediactric diabetic, and pediactric genetic history of APOC3.